Critically Ill Patients with Coronavirus Disease 2019 in a Designated ICU: Clinical Features and Predictors for

Zhao-Hua Wang1, Chang Shu2, Xiao Ran1

  • 1Department of Critical Care Medicine, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, People's Republic of China.

Insights

Older age, arrhythmia, and high Sequential Organ Failure Assessment (SOFA) scores are key indicators for mortality risk in critically ill patients with COVID-19. Early medical intervention is crucial for these high-risk individuals.

Area of Science:

  • Critical Care Medicine
  • Infectious Diseases
  • Epidemiology

Background:

  • The COVID-19 pandemic has a significant global mortality rate.
  • Prognostic factors for severe COVID-19 cases remain incompletely understood.
  • Identifying predictors of mortality is crucial for managing critically ill patients.

Purpose of the Study:

  • To identify significant prognostic factors associated with mortality in intensive care unit (ICU) patients diagnosed with COVID-19.
  • To elucidate demographic, clinical, and laboratory predictors of adverse outcomes in severe COVID-19.

Main Methods:

  • A cohort of 59 critically ill COVID-19 patients from an ICU was analyzed.
  • Comprehensive data including epidemiological, demographic, clinical, laboratory, and radiological information were collected.
  • Statistical analysis was performed to define prognostic factors for patient mortality.

Main Results:

  • The study included patients aged 67.4±11.3 years; 51 had comorbidities, and 41 died.
  • Deceased patients were older, had more smoking history, fatigue, diarrhea, organ injuries, lymphopenia, thrombocytopenia, impaired immunity, and heightened cytokine release compared to survivors.
  • Independent risk factors for mortality included age >70 years (OR=2.76), arrhythmia (OR=4.76), and SOFA score >4 (OR=5.16).

Conclusions:

  • Critically ill COVID-19 patients over 70 years old, those with arrhythmia, or a SOFA score above 4 face a high mortality risk.
  • These identified factors necessitate prioritized medical intervention and closer monitoring.
  • Understanding these prognostic factors can guide clinical decision-making and resource allocation in managing severe COVID-19.
Abstract

Related Concept Videos

Acute Respiratory Failure-II01:21

Acute Respiratory Failure-II

Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
859
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
677
Acute Respiratory Failure-I01:21

Acute Respiratory Failure-I

Acute respiratory failure is a condition characterized by the inability of the lungs to perform their primary function: gas exchange. This failure leads to insufficient oxygen levels (hypoxemia) in the blood, elevated carbon dioxide levels (hypercapnia), or both, causing critical impairment in organ function.
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
637
Acute Respiratory Failure-III01:30

Acute Respiratory Failure-III

Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without...
597
Acute Respiratory Failure-V01:29

Acute Respiratory Failure-V

The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
340
COPD: Pathogenesis and Clinical Features01:20

COPD: Pathogenesis and Clinical Features

Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
1.6K